48,454
edits
Difference between revisions of "Prostate cancer grading"
Jump to navigation
Jump to search
Prostate cancer grading (view source)
Revision as of 16:37, 10 October 2018
, 16:37, 10 October 2018→When to use/not to use
| (One intermediate revision by the same user not shown) | |||
| Line 21: | Line 21: | ||
====When to use/not to use==== | ====When to use/not to use==== | ||
The ''College of American Pathologist'' synoptic says:<ref>Srigley JR ''et al.'', "Protocol for the Examination of Specimens From Patients With Carcinoma of the Prostate Gland", College of American Pathologists, Version: 4.0.3.0. (June 2017), Accessed on: 10 October 2018.</ref> | The ''College of American Pathologist'' synoptic (''Cancer Protocol Template'') says:<ref>Srigley JR ''et al.'', "Protocol for the Examination of Specimens From Patients With Carcinoma of the Prostate Gland", College of American Pathologists, Version: 4.0.3.0. (June 2017), Accessed on: 10 October 2018.</ref> | ||
*Grade all prostate specimens with adenocarcinoma except those with prior treatment changes (e.g. radiation therapy or anti-androgen | *Grade all prostate specimens with adenocarcinoma except those with prior treatment changes (e.g. radiation therapy changes or anti-androgen changes). | ||
====Tertiary Gleason pattern==== | ====Tertiary Gleason pattern==== | ||